Bio-Rad Laboratories Class A
488 hedge funds and large institutions have $11.2B invested in Bio-Rad Laboratories Class A in 2021 Q1 according to their latest regulatory filings, with 64 funds opening new positions, 202 increasing their positions, 147 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
488
Holders Change
+1
Holders Change %
+0.21%
% of All Funds
8.59%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.11%
New
64
Increased
202
Reduced
147
Closed
60
Calls
$22.9M
Puts
$14.2M
Net Calls
+$8.73M
Net Calls Change
+$9.98M
Top Buyers
| 1 |
Marshall Wace
London,
United Kingdom
|
+$114M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$66.6M |
| 3 |
N
Natixis
Paris,
France
|
+$52.7M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$45.2M |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
+$32.3M |
Top Sellers
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
-$143M |
| 2 |
ACM
Atlanta Capital Management
Atlanta,
Georgia
|
-$141M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$86.7M |
| 4 |
HM
HealthCor Management
New York
|
-$81.7M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$69M |
